ℹ️
🇬🇧
Search
Search for people relevant for "beta blocker"
beta blocker
Person
Class
Person
Publication
Programmes
Export current view
MUDr. Heřman Mann Ph.D.
Academic staff at First Faculty of Medicine
143 publications
Publications
publication
New pro-inflammatory cytokine IL-40 is produced by activated neutrophils and plays a role in the early stages of seropositive rheumatoid arthritis
2023 |
First Faculty of Medicine, Second Faculty of Medicine
publication
Effect of an 8-Week Tailored Physiotherapy Program on Sexual Health in Women with Scleroderma and Myositis: A Controlled Pilot Study
2023 |
First Faculty of Medicine, Faculty of Physical Education and Sport
publication
Cardiovascular risk in myositis patients compared with the general population
2023 |
First Faculty of Medicine, Faculty of Physical Education and Sport
publication
Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational study
2023 |
First Faculty of Medicine
publication
Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome
2023 |
First Faculty of Medicine
publication
Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies
2023 |
First Faculty of Medicine
publication
Hsp90 Levels in Idiopathic Inflammatory Myopathies and Their Association With Muscle Involvement and Disease Activity: A Cross-Sectional and Longitudinal Study
2022 |
First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
publication
Hsp90 as a Myokine: Its Association with Systemic Inflammation after Exercise Interventions in Patients with Myositis and Healthy Subjects
2022 |
First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
publication
Cardiovascular Risk in Myositis Patients Compared to the General Population: Preliminary Data From a Single-Center Cross-Sectional Study
2022 |
First Faculty of Medicine, Faculty of Physical Education and Sport
publication
Real-world Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients with Psoriatic Arthritis in Thirteen European Countries
2022 |
First Faculty of Medicine
Load more publications (133)
Loading network view...